272 related articles for article (PubMed ID: 18726891)
21. [New treatment of peritoneal carcinomatosis from colorectal cancer. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy].
Iversen LH; Rasmussen PC; Laurberg S
Ugeskr Laeger; 2007 Sep; 169(38):3179-81. PubMed ID: 17910824
[TBL] [Abstract][Full Text] [Related]
22. Results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer.
Glockzin G; Ghali N; Lang SA; Schlitt HJ; Piso P
J Surg Oncol; 2009 Sep; 100(4):306-10. PubMed ID: 19697436
[TBL] [Abstract][Full Text] [Related]
23. Intraperitoneal paclitaxel: a possible impact of regional delivery for prevention of peritoneal carcinomatosis in patients with gastric carcinoma.
Kodera Y; Ito Y; Ito S; Ohashi N; Mochizuki Y; Yamamura Y; Koike M; Fujiwara M; Nakanishi H; Nakao A
Hepatogastroenterology; 2007; 54(75):960-3. PubMed ID: 17591103
[TBL] [Abstract][Full Text] [Related]
24. [Cancers of the stomach and peritoneal carcinoses: will hyperthermia be a new therapeutic approach?].
Gilly FN; Carry PY; Sayag AC; Panteix GG; Bienvenu J; Brachet A; Salle B; Braillon G
Ann Chir; 1993; 47(5):414-8. PubMed ID: 8215164
[TBL] [Abstract][Full Text] [Related]
25. Treatment of peritoneal carcinomatosis in gastric cancers.
Brigand C; Arvieux C; Gilly FN; Glehen O
Dig Dis; 2004; 22(4):366-73. PubMed ID: 15812161
[TBL] [Abstract][Full Text] [Related]
26. Cytoreduction and intraperitoneal chemotherapy for peritoneal carcinomatosis of ovarian cancer.
Lee JM
Cancer Treat Res; 2007; 134():375-85. PubMed ID: 17633067
[No Abstract] [Full Text] [Related]
27. Drugs, carrier solutions and temperature in hyperthermic intraperitoneal chemotherapy.
Kusamura S; Dominique E; Baratti D; Younan R; Deraco M
J Surg Oncol; 2008 Sep; 98(4):247-52. PubMed ID: 18726886
[TBL] [Abstract][Full Text] [Related]
28. [Collateral effects of intraoperative hyperthermic chemotherapy in peritoneal carcinomatosis].
Izzo L; Galati G; D'Aprile MR; Stasolla A; Kharrub Z; Maccioni F; Sassayannis PG; D'Arielli D; Marini M; Gazzanelli S; Caputo M
G Chir; 2004; 25(1-2):43-6. PubMed ID: 15112761
[TBL] [Abstract][Full Text] [Related]
29. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival in selected patients with peritoneal carcinomatosis from abdominal and pelvic malignancies: results of 21 cases.
Yang XJ; Li Y; al-shammaa Hassan AH; Yang GL; Liu SY; Lu YL; Zhang JW; Yonemura Y
Ann Surg Oncol; 2009 Feb; 16(2):345-51. PubMed ID: 19018599
[TBL] [Abstract][Full Text] [Related]
30. Prevention of peritoneal carcinomatosis in mice with combination hyperthermal intraperitoneal chemotherapy and IL-2.
Bevanda M; Orsolic N; Basic I; Vukojevic K; Benkovic V; Horvat Knezevic A; Lisicic D; Dikic D; Kujundzic M
Int J Hyperthermia; 2009 Mar; 25(2):132-40. PubMed ID: 19337913
[TBL] [Abstract][Full Text] [Related]
31. Safety of gastric resections during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis.
Piso P; Slowik P; Popp F; Dahlke MH; Glockzin G; Schlitt HJ
Ann Surg Oncol; 2009 Aug; 16(8):2188-94. PubMed ID: 19408049
[TBL] [Abstract][Full Text] [Related]
32. Cytoreductive surgery and heated intra-peritoneal chemotherapy in the treatment of peritoneal carcinomatosis of colorectal origin: the need for practice altering data.
Esquivel J; Nissan A; Stojadinovic A
J Surg Oncol; 2008 Nov; 98(6):397-8. PubMed ID: 18780291
[No Abstract] [Full Text] [Related]
33. [Selection criteria for peritonectomy with hyperthermic intraoperative chemotherapy (HIPEC) in peritoneal carcinomatosis].
Königsrainer I; Aschoff P; Zieker D; Beckert S; Glatzle J; Pfannenberg C; Miller S; Hartmann JT; Schroeder TH; Brücher BL; Königsrainer A
Zentralbl Chir; 2008 Sep; 133(5):468-72. PubMed ID: 18924046
[TBL] [Abstract][Full Text] [Related]
34. Gastrectomy, peritonectomy, and perioperative intraperitoneal chemotherapy: the evolution of treatment strategies for advanced gastric cancer.
Sugarbaker PH; Yu W; Yonemura Y
Semin Surg Oncol; 2003; 21(4):233-48. PubMed ID: 14648781
[TBL] [Abstract][Full Text] [Related]
35. Intraperitoneal treatment for peritoneal mucinous carcinomatosis of appendiceal origin after operative management: long-term follow-up of the Mayo Clinic experience.
Schomas DA; Miller RC; Donohue JH; Gill S; Thurmes PJ; Haddock MG; Quevedo JF; Gunderson LL
Ann Surg; 2009 Apr; 249(4):588-95. PubMed ID: 19300231
[TBL] [Abstract][Full Text] [Related]
36. [The techniques of peritonectomy and hyperthermic intraperitoneal chemotherapy].
Lang SA; Glockzin G; Dahlke MH; Popp FC; Agha A; Schlitt HJ; Piso P
Zentralbl Chir; 2009 Sep; 134(5):443-9. PubMed ID: 19492282
[TBL] [Abstract][Full Text] [Related]
37. Cytoreductive surgery plus intraperitoneal chemohyperthermia in patients with colorectal cancer at high risk for local-regional recurrence.
Lefevre JH; Elias DM
Cancer J; 2009; 15(3):200-3. PubMed ID: 19556905
[TBL] [Abstract][Full Text] [Related]
38. Hyperthermic intraperitoneal chemotherapy: nomenclature and modalities of perfusion.
Glehen O; Cotte E; Kusamura S; Deraco M; Baratti D; Passot G; Beaujard AC; Noel GF
J Surg Oncol; 2008 Sep; 98(4):242-6. PubMed ID: 18726885
[TBL] [Abstract][Full Text] [Related]
39. Swedish experience with peritonectomy and HIPEC. HIPEC in peritoneal carcinomatosis.
van Leeuwen BL; Graf W; Pahlman L; Mahteme H
Ann Surg Oncol; 2008 Mar; 15(3):745-53. PubMed ID: 18057988
[TBL] [Abstract][Full Text] [Related]
40. [Adjuvant hyperthermic intraperitoneal chemotherapy in patients with colorectal cancer at risk of carcinomatosis: preliminary experience of a single centre].
Virzi S; Iusco D; Grassi A; Navarra G; Ismail I; Panetta A; Bonomi S
Chir Ital; 2008; 60(6):825-30. PubMed ID: 19256273
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
